Kintsugi Mindfull Wellness, Inc.

Kintsugi’s AI-powered voice biomarker platform has been validated for detecting signs of depression and anxiety from short clips of free-form speech. The solution is already integrated into telehealth systems, call centers, and remote patient monitoring applications. It is used by major payer organizations and large health systems to support early identification and triage for mental health needs. The company’s data set is described as 110 times larger than the next largest competitor in this space, supporting robust detection across diverse populations. Clinical partnerships include Children’s Hospital Colorado and Joe DiMaggio Children’s Hospital.